drugset / Trial / NCT06787222

Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 and Skin Microbiome

NCT06787222

Phase 2/3 Active not recruiting 26 enrolled Hasanuddin University
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to investigate the effectivity and safety of mild to moderate acne vulgaris therapy using Zingiber officinale 5 % transdermal patch. Researcher will compare both half faces (split face); one side as treatment side where patch is used, and another side as control. Patient will be asked to apply tretinoin 0,025% cream nightly. After applying tretinoin 0,025% on whole face, patient will be asked to apply patch on a pustule on one half face, and no patch will be used on another half face. Total lesion count will be assessed before treatment and 21 days after treatment. Specimen for skin microbiome and interleukin examination will be collected before and 21 days after treatment.

Timeline

Start
2024-11-03
Primary completion
2025-08-25
Completion
2025-10-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ginger Traditional medicine (herbal / TCM) 0.05 % Other
Comparator Tretinoin Small molecule 0.025 % Topical

Indications